E2F6 was significantly correlated with monocyte markers (CD86, CD115), TAM markers (CD68, IL10), M1 macrophage markers (IRF5), and M2 macrophage markers (VSIG4, MS4A4A) in GBM (P < 0.0001; Table 2). Here, E2F6 is linked to glioblastoma.